Table 1 Tzero of NeRCaMs treated with different concentrations of doxorubicin (10–100 μ M) with or without 1 mM monoHER or preinfection with AdCat (MOI=50). Values are mean (n=3) ±s.e.m.

From: A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro

Dox

T zero (h)

μ M

Dox

Dox + AdCat

Dox + MH

10

72.0±0.0

72.0±0.0

>72

25

42.0±6.0

48.0±0.0

>72

50

26.0±2.0

24.0±0.0

>72

100

9.0±0.0

7.0±2.0

>72